Advertisement

Separate Renal Function Evaluation by DMSA

  • C. C. Abbou
  • J. L. Moretti
  • D. Chopin
  • E. Sanabria
  • M. Msallag
  • T. Nebout
  • J. Auvert
Conference paper

Abstract

Radioisotope exploration of the kidneys allows separate renal function determination without retrograde catheterization (Taylor and Nelson 1979). Dimercaptosuccinic acid (DMSA) is a chelate which was first used as a protective agent against irradiation, in the deintoxication of heavy metals, and in the treatment of schistomiasis (Cannava and Cugarra 1961; Fraga de Azevedo and Braganca 1966). DMSA labeled with technetium 99m (DMSA sn 99Tc) was proposed to obtain images of renal parenchyma (Enlander et al. 1974; Lin et al. 1974; Arnold et al. 1975; Mandmaker et al. 1975; Vanlic Razumedic and Gorkic 1976; Daly et al. 1977); afterwards it was used as an index for separate renal function (Moretti et al. 1975; Raynaud et al. 1975; Dumery et al. 1977; Rapin et al. 1979).

Keywords

Solitary Kidney Dimercaptosuccinic Acid Differential Renal Function Renal Scanning Renal Artery Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arnold RW, Subramanian G, McAfee JG, Blair RJ, Thomas FD (1975) Comparison of 99m Tc complexes for renal imaging. J Nucl Med 16:357–367PubMedGoogle Scholar
  2. Bin Gham JB, Maisey MN (1978) An evaluation of the use of 99m Tc dimercaptosuccinic acid (DMSA) as a static renal imaging agent. Br J Radiol 51:599–607CrossRefGoogle Scholar
  3. Cannava A, Cugurra F (1961) Pharmacologic activity and antitoxic properties of dimercaptosuccini acids. Arch Int Pharmacodyn Ther 131:283–300PubMedGoogle Scholar
  4. Cosgrove E, Raphael J (1968) The use of xenon 133 to measure blood flow in patients. Br J Surg 55:245PubMedCrossRefGoogle Scholar
  5. Daly MJ, Jones WA, Rudd TG, Tremann JA (1977) Differential Tc 99m dimercaptosuccinic and renal localisation, correlation with renal function. J Nucl Med 18:594–595Google Scholar
  6. Dumery JP, Reaulth, Rapin JR, Moretti JL, Galle P (1977) Study of the fixation of a complexe dimercaptosuccinic acid (DMSA) technitium. Comm. First European Congress on Nuclear Medecine, LausanneGoogle Scholar
  7. Enlander D, Weber PH, Dos Remedios LV (1974) Renal cortical imaging in 35 patients superior quality with 99m Tc DMSA. J Nucl Med 15:743–749PubMedGoogle Scholar
  8. Evrin PE, Wibell (1973) Serum ß2 microglobulin in various disorder. Clin Chim Acta 43:183–187PubMedCrossRefGoogle Scholar
  9. Fragade Azevedo J, Braganca G (1966) Absorption and elimination of Atisban labeled with 12n Sb. An Inst Med Trop (Lisbon) 23:191–198Google Scholar
  10. Johannsen B, Spiles H, Syhre R (1979) Study on complexation of Tc 99m with dimercaptosuccinic acids with regards to organ specificity of Tc 99m radiopharmacocorticals. Eur J Nucl Med 2:148Google Scholar
  11. Kawamura J, Mosokana S, Yoshida O (1978) Validity of 99m Tc dimercaptosuccinic acid renal uptake for an assessment of individual kidney function. J Urol 119:305–309PubMedGoogle Scholar
  12. Krejcarer GE et al. (1976) The structures of stannous dimercaptosuccinic acid chelates. J Nucl Med 17:565Google Scholar
  13. Laroche D, Travert G (1979) Etude physicochimique et biologique d’un agent scintigraphique rénal. J Fr Biophys Med Nucl 3, 4:181–198Google Scholar
  14. Lin TH, Khentigan A, Winchell WS (1974) A 99m Tc chelate substitute for organomercurial renal agents. J Nucl Med 15:34–35PubMedGoogle Scholar
  15. Mandmaker H, Young BW, Lowenstein LM (1975) Clinical experience with 99m Tc DMSA, a new renal imaging agent. J Nucl Med 16:28–32Google Scholar
  16. Moretti JL, Meignan M, Dumery JP, Galle P, Auvert J, Lagrue G (1975) Le dimercaptosuccinate de Technetium en exploration rénale 99m Tc DMSA. Nouv Presse Méd 19:1430Google Scholar
  17. O’Reilly PM et al. (1977) Dynamic scintigraphy in clinical urology. Br J Urol 49:575–582PubMedCrossRefGoogle Scholar
  18. Price RR, Born ML, Jones JP (1979) Comparison of differential renal function determination by Tc 99m DMSA, Tc 99m DTPA, I 131 Hippuran and ureteral catheterization. J Nucl Med 20:631Google Scholar
  19. Rapin JR, Moretti JL, Compagnon M (1979) Fixation rénale du complexe doublement marqué Acide Dimercapto-2-3-succinique 14C,2,3 Sn 99m Tc. Comm. XX Coll. Med. Nucl. Bordeaux, 20-22 Sept, I, 21–22Google Scholar
  20. Raynaud C (1975) La fixation rénale du mercure et du DMSA. In: Raynaud C (ed) Compterendu du llème Colloque International sur la Fixation Rénale. Svce Doc. C.E.N.-Saclay, Paris, 24-25 Oct.Google Scholar
  21. Taplin GV, Dore EK, Johnson DE (1963) The quantitative radiorenogram for total and differential renal blood flow measurement. J Nucl Med 4:404PubMedGoogle Scholar
  22. Taylor A, Nelson M (1979) Current status of quantitative differential renal scanning. Applied Radiology, May, pp 111–114Google Scholar
  23. Taylor A, Hollenbeck J, Hagan PL (1979) DMSA scanning: an index of relative renal plasma flow. J Nucl Med 20:630–631Google Scholar
  24. Tauxe WN, Burfe EC (1968) Kidney depth and isotope renography. J Nucl Med 9:225PubMedGoogle Scholar
  25. Vanlic Razumedic NM, Gorkic DA (1976) Studies of chemical and biological properties of 99m Tc DMS renal imaging agent. Eur J Nucl Med 1:232–242Google Scholar
  26. Wibell L, Evrin PE, Berggard I (1973) Serum ß2 microglobulin in renal disease. Nephron 10:320–331PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • C. C. Abbou
  • J. L. Moretti
  • D. Chopin
  • E. Sanabria
  • M. Msallag
  • T. Nebout
  • J. Auvert

There are no affiliations available

Personalised recommendations